DK1414414T3 - Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet - Google Patents

Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet

Info

Publication number
DK1414414T3
DK1414414T3 DK02754615T DK02754615T DK1414414T3 DK 1414414 T3 DK1414414 T3 DK 1414414T3 DK 02754615 T DK02754615 T DK 02754615T DK 02754615 T DK02754615 T DK 02754615T DK 1414414 T3 DK1414414 T3 DK 1414414T3
Authority
DK
Denmark
Prior art keywords
water
cross
drug
charged
insoluble drugs
Prior art date
Application number
DK02754615T
Other languages
Danish (da)
English (en)
Inventor
Massimo Bresciani
Lorenzo Magarotto
Luca Dobetti
Original Assignee
Eurand Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Pharmaceuticals Ltd filed Critical Eurand Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK1414414T3 publication Critical patent/DK1414414T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK02754615T 2001-06-29 2002-06-03 Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet DK1414414T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE20010628 2001-06-29
PCT/EP2002/006052 WO2003002097A1 (fr) 2001-06-29 2002-06-03 Procede d'activation thermodynamique de medicaments insolubles dans l'eau charges dans des polymeres reticules

Publications (1)

Publication Number Publication Date
DK1414414T3 true DK1414414T3 (da) 2008-03-03

Family

ID=11042810

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02754615T DK1414414T3 (da) 2001-06-29 2002-06-03 Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet

Country Status (11)

Country Link
US (1) US8889182B2 (fr)
EP (1) EP1414414B1 (fr)
JP (1) JP2005503360A (fr)
AT (1) ATE377413T1 (fr)
AU (1) AU2002321061B2 (fr)
CA (1) CA2452575C (fr)
DE (1) DE60223382T2 (fr)
DK (1) DK1414414T3 (fr)
ES (1) ES2295379T3 (fr)
NZ (1) NZ530826A (fr)
WO (1) WO2003002097A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481390C (fr) * 2002-04-12 2012-11-27 Elan Pharma International Ltd. Preparations de megestrol nanoparticulaires
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
WO2005012254A1 (fr) 2003-07-22 2005-02-10 Arena Pharmaceuticals, Inc. Derives de diaryl et arylheteroaryl uree utilises en tant que modulateurs du recepteur de la serotonine 5-ht2a utiles pour la prophylaxie et le traitement de troubles associes a ce dernier
JP2007535774A (ja) * 2004-04-30 2007-12-06 ヒルクレスト・ラボラトリーズ・インコーポレイテッド 自由空間ポインティングデバイスにおける意図的でない動きを除去するための方法およびデバイス
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
EP2190844B3 (fr) 2007-08-15 2013-07-17 Arena Pharmaceuticals, Inc. Dérivés d'imidazo[1,2-a]pyridine utilisés comme modulateurs du récepteur sérotoninergique 5-ht2a dans le traitement des troubles qui lui sont associés
WO2009123714A2 (fr) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Procédés de préparation de dérivés de pyrazole utiles comme modulateurs du récepteur de la sérotonine 5-ht<sb>2a</sb>
CA2725578A1 (fr) * 2008-04-24 2009-10-29 Evestra, Inc. Formes galeniques contraceptives orales renfermant un progestogene disperse dans un polymere gastroresistant et renfermant en outre un oestrogene
SI2364142T1 (en) 2008-10-28 2018-06-29 Arena Pharmaceuticals, Inc. The modulators of the serotonin 5-HT2A receptor are useful in the treatment of disorders associated with it
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
ITMI20120092A1 (it) 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
MX2017016413A (es) 2015-06-12 2018-08-01 Axovant Sciences Gmbh Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamineto de un trastorno conductual del sueño rem.
MX2018000465A (es) 2015-07-15 2018-09-17 Axovant Sciences Gmbh Derivados de diaril y arilheteroaril urea como moduladores del receptor de serotonina 5-ht2a útiles para la profilaxis y el tratamiento de alucinaciones asociadas con una enfermedad neurodegenerativa.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2634004B2 (de) 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
DE3320583A1 (de) 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
IT1298574B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione

Also Published As

Publication number Publication date
DE60223382T2 (de) 2008-09-11
US20040213840A1 (en) 2004-10-28
AU2002321061B2 (en) 2006-08-24
CA2452575A1 (fr) 2003-01-09
JP2005503360A (ja) 2005-02-03
DE60223382D1 (de) 2007-12-20
NZ530826A (en) 2004-09-24
EP1414414B1 (fr) 2007-11-07
CA2452575C (fr) 2010-11-02
EP1414414A1 (fr) 2004-05-06
ES2295379T3 (es) 2008-04-16
WO2003002097A1 (fr) 2003-01-09
US8889182B2 (en) 2014-11-18
ATE377413T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
DK1414414T3 (da) Fremgangsmåde til termodynamisk aktivering af vand-uoplöselige lægemidler hvormed tværbundne polymerer er ladet
DK1163274T3 (da) Fremgangsmåde til tværbinding af hyaluronsyre til polymerer
WO2001047572A3 (fr) Dispositif et constituant actif destines a inhiber la formation de thrombus-matrice cellulaire inflammatoire
MX2009002653A (es) Derivados de acido hialuronico obtenidos via reticulacion de &#34;quimica modular&#34;.
ATE541587T1 (de) Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen
DE69903351D1 (de) Vernetzte hyaluronsäure und ihre medizinischen verwendungen
DK0910412T3 (da) Hydrolyserbare hydrogeler til kontrolleret frigørelse
ATA7692003A (de) Vernetztes, ultra-hochmolekulares polyethylen (uhmw-pe)
ATE355829T1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
ES2180982T3 (es) Metodo para fabricar dispositivos de liberacion controlada basados en polimeros.
AU2003266947A1 (en) A hydrogel
CY1105515T1 (el) Μεθοδος παρασκευης στερεων διασπορων
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
ATE520419T1 (de) Verfahren zur herstellung von polymer-konjugaten von doxorubicin mit ph-kontrollierter freisetzung des arzneimittels
ATE486583T1 (de) Pharmazeutische zusammensetzung enthaltend anastrozol
AR050637A1 (es) Implantes y microesferas de liberacion prolongada de farmacos de uso oftalmico y metodos para prepararlos
ATE310026T1 (de) Hydrophile makromolekulare verbindungen
ES2060715T3 (es) Medicamentos escasamente solubles inmovilizados en substancias polimericas de una manera adecuada para incrementar su grado de disolucion.
DK1061948T3 (da) Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf
DE50211023D1 (de) Enzymatische synthese von zuckeracrylaten
WO2003063824A3 (fr) Composition pharmaceutique
WO2002004544A3 (fr) Polymeres et procedes de polymerisation ameliores
EP1258254A4 (fr) Preparations a liberation lente contenant un compose physiologiquement actif peu soluble dans l&#39;eau et methode de production et d&#39;utilisation desdites preparations
CN107814888B (zh) 一种煤基聚合物水凝胶及其制备方法
BR0112258A (pt) Sistema de entrega de droga para drogas pouco solúveis em água